During the past decade, Intercept Pharmaceuticals, Inc conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Intercept Pharmaceuticals, Inc" #1 collaborator was "Global PBC Study Group" with 2 trials as a collaborator, "Syneos Health" with 2 trials as a collaborator, "Target RWE" with 2 trials as a collaborator, "UK PBC Group" with 1 trials as a collaborator and "UK PBC Study Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Intercept Pharmaceuticals, Inc" are "Primary Biliary Cholangitis" (2 trials). Many other conditions were trialed in "Intercept Pharmaceuticals, Inc" in a lesser frequency.

Most popular intervention types in "Intercept Pharmaceuticals, Inc" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Obeticholic Acid 10 MG" (2 trials), "Obeticholic Acid 5 MG" (2 trials) and "Standard of Care: UDCA" (2 trials). Other intervention names were less common.

The vast majority of trials in "Intercept Pharmaceuticals, Inc" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Intercept Pharmaceuticals, Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in Intercept Pharmaceuticals, Inc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Intercept Pharmaceuticals, Inc, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".